Good Morning Group,

Article of interest.  You may want to check if your Institution has any Vioxx studies.

Thanks

scott

Scott Davis, CRA
Sponsored Programs Administrator
Office of Research Administration
University of Oklahoma Health Sciences Center
Ph: 405.271.2090   Fax: 405.271.8651
E-mail: xxxxxx@ouhsc.edu

Merck Pulls Vioxx Painkiller
From Market, and Stock Plunges

September 30, 2004
 By TERENCE NEILAN

Merck said it voluntarily pulled the drug
after new data from a clinical trial found
an increased risk of heart attack and stroke.

http://www.nytimes.com/2004/09/30/business/30CND-MERCK.html?ex=1097557438&ei=1&en=b9d7d6b794d11311

For general information about NYTimes.com, write to
xxxxxx@nytimes.com.

Copyright 2004 The New York Times Company

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================